Dry ice

Wag Tantrum Gourmet Organic Dog Food Supports Women's History Month with New Opportunities for Clients of The Women's Home

Retrieved on: 
Tuesday, March 29, 2022
Amazon, Human, Dry ice, Nutrient, Women's Home Industries, Skin, Veterinarian, Program, Woman, Cancer, Health, Nutritionist, Association, Women, Dog, Women's History Month, Association of American Feed Control Officials, Food, Partnership, AAFCO, Animal, Interior design, Medicine, Feed manufacturing

Wag Tantrum is an all-organic, human-grade dog food company that has been providing delicious and nutritious dog meals since 2016.

Key Points: 
  • Wag Tantrum is an all-organic, human-grade dog food company that has been providing delicious and nutritious dog meals since 2016.
  • One way Wag Tantrum does this is by hiring clients from The Women's Home.
  • Lily refused to eat traditional dog food, so Marshall began testing different recipes, and thus Wag Tantrum was born.
  • Wag Tantrum is on a mission to improve your dog's health with its 100 percent organic and human-grade recipes.

Thermal Custom Packaging Provides Dry Ice Alternative for Allograft Transportation

Retrieved on: 
Tuesday, March 8, 2022
Dry ice, PCM, Inc., Allotransplantation, TCP, COVID, Patient, Vaccine, Hospital, PCM, Public sector banks in India, Solution, Temperature, American Association, COVID-19, Association, CEO, American Association of Tissue Banks, Environment, Health, Transport, Safety, Sports medicine, CO2, AATB, RNA transfection, Pharmaceutical industry, Heating, ventilation, and air conditioning, Cole

HIALEAH, Fla., March 8, 2022 /PRNewswire/ --Thermal Custom Packaging (TCP), a company specializing in transportation solutions for COVID vaccines, sensitive healthcare and military cargo, provides essential storage for allograft transportation using phase change material (PCM).To avoid potential barriers to treating patients with an allograft-based procedure due to poor storage and transportation of the allograft, TCP has crafted the PC-21 tote, an ultracold -21 C phase change material carrying tote.

Key Points: 
  • HIALEAH, Fla., March 8, 2022 /PRNewswire/ --Thermal Custom Packaging (TCP), a company specializing in transportation solutions for COVID vaccines, sensitive healthcare and military cargo, provides essential storage for allograft transportation using phase change material (PCM).To avoid potential barriers to treating patients with an allograft-based procedure due to poor storage and transportation of the allograft, TCP has crafted the PC-21 tote, an ultracold -21 C phase change material carrying tote.
  • "Currently many hospitals and surgery centers use dry ice to store and transport allografts at the proper temperatures, but dry ice is not foolproof," says Founder and CEO of Thermal Custom Packaging, Dr. Clifford Glade.
  • Thermal Custom Packaging (TCP) is a medical product manufacturerspecializing in cold-chain transport solutions, insulated containers (totes), and the chemical reactions that maintain them.
  • The company is the force behind the PC-21, the latest transport technology for mRNA COVID-19 vaccines and antibioticsfrozen without dry ice.

Thermal Custom Packaging Provides Dry Ice Alternative for Allograft Transportation

Retrieved on: 
Tuesday, March 1, 2022
Packaging, Medical Supplies, Health, Surgery, Manufacturing, Other Health, General Health, PCM, Inc., Allotransplantation, TCP, COVID, Patient, Hospital, PCM, Dry ice, Public sector banks in India, Solution, Multimedia, Temperature, American Association, COVID-19, Association, CEO, American Association of Tissue Banks, Environment, Health, Transport, Safety, Sports medicine, CO2, AATB, RNA transfection, Pharmaceutical industry, Heating, ventilation, and air conditioning, Cole

Thermal Custom Packaging (TCP), a company specializing in transportation solutions for COVID vaccines, sensitive healthcare and military cargo, provides essential storage for allograft transportation using phase change material (PCM).

Key Points: 
  • Thermal Custom Packaging (TCP), a company specializing in transportation solutions for COVID vaccines, sensitive healthcare and military cargo, provides essential storage for allograft transportation using phase change material (PCM).
  • Currently many hospitals and surgery centers use dry ice to store and transport allografts at the proper temperatures, but dry ice is not foolproof, says Founder and CEO of Thermal Custom Packaging , Dr. Clifford Glade.
  • Thermal Custom Packaging (TCP) is a medical product manufacturerspecializing in cold-chain transport solutions, insulated containers (totes), and the chemical reactions that maintain them.
  • The company is the force behind the PC-21 , the latest transport technology for mRNA COVID-19 vaccines and antibioticsfrozen without dry ice.

Arctic Glacier Premium Ice Acquires Massachusetts Brookline Ice Company

Retrieved on: 
Thursday, February 24, 2022
Construction & Property, Other Manufacturing, Supermarket, Convenience Store, Food, Beverage, Other Construction & Property, Manufacturing, Retail, Associate, ME, DSD, Dry ice, Acquisition, Glacier, Ice, Supermarket, CEO, Party, Hotel, LLC, Arctic Glacier

Arctic Glacier, LLC , a leading provider of premium ice products and related services, announces the acquisition of the bulk ice manufacturing, dry ice, and distribution business of Brookline Ice Company of Boston, MA.

Key Points: 
  • Arctic Glacier, LLC , a leading provider of premium ice products and related services, announces the acquisition of the bulk ice manufacturing, dry ice, and distribution business of Brookline Ice Company of Boston, MA.
  • Arctic Glacier is pleased to offer our premium ice products to the retail, hospitality and commercial businesses of Massachusetts, New Hampshire and surrounding areas.
  • We warmly welcome the customers and Associates of Brookline Ice Company to our team, said Richard Wyckoff, CEO and President of Arctic Glacier, LLC.
  • The Brookline Ice Company is proud of its 100 plus year tradition providing ice products and services, to fulfill the needs of the hospitality, retail and commercial businesses of Massachusetts.

Vaccine Cold Chain Logistics Market worth $4.59 billion by 2028 - Exclusive Report by InsightAce Analytic

Retrieved on: 
Monday, February 21, 2022
Well, PAREXEL, Region, RNA transfection, Government, DHL, COVID-19, Growth, Investment, Awareness, Forecast, EQT, CEVA Logistics, Clinical trial, Safety, United Parcel Service, Transport, US, Ministry of Health & Wellness, Rail transport by country, Method, Infection, Container, Dry ice, DB Schenker, Mode, Goldman Sachs, CAGR, FedEx, GAC, Pharmaceutical industry, Food delivery, Vaccine, Aquaculture, Vaccine

According to the latest market research report the global vaccine cold chain logistics market size was valued at US$ 3.12 Billion in 2021, and it is expected to reach US$ 4.59 Billion in 2028, recording a promising CAGR of 5.2% from 2022 to 2028.

Key Points: 
  • According to the latest market research report the global vaccine cold chain logistics market size was valued at US$ 3.12 Billion in 2021, and it is expected to reach US$ 4.59 Billion in 2028, recording a promising CAGR of 5.2% from 2022 to 2028.
  • Therefore, the rising R&D initiatives will likely offer new growth opportunities for the vaccine cold chain logistics market in the next few years.
  • Vaccine Cold Chain Logistics MarketRegional Analysis: North America majorly contributed to the vaccine cold chain logistics market in 2021 owing to the surging government initiatives for logistics infrastructure and the growing demand for cold chain storages systems.
  • The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 byServices
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Packaging Methods
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Mode of Transportation
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Holding Temperature Range
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Container
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Region

Vaccine Cold Chain Logistics Market worth $4.59 billion by 2028 - Exclusive Report by InsightAce Analytic

Retrieved on: 
Monday, February 21, 2022
Well, PAREXEL, Region, RNA transfection, Government, DHL, COVID-19, Growth, Investment, Awareness, Forecast, EQT, CEVA Logistics, Clinical trial, Safety, United Parcel Service, Transport, US, Ministry of Health & Wellness, Rail transport by country, Method, Infection, Container, Dry ice, DB Schenker, Mode, Goldman Sachs, CAGR, FedEx, GAC, Pharmaceutical industry, Food delivery, Vaccine, Aquaculture, Vaccine

According to the latest market research report the global vaccine cold chain logistics market size was valued at US$ 3.12 Billion in 2021, and it is expected to reach US$ 4.59 Billion in 2028, recording a promising CAGR of 5.2% from 2022 to 2028.

Key Points: 
  • According to the latest market research report the global vaccine cold chain logistics market size was valued at US$ 3.12 Billion in 2021, and it is expected to reach US$ 4.59 Billion in 2028, recording a promising CAGR of 5.2% from 2022 to 2028.
  • Therefore, the rising R&D initiatives will likely offer new growth opportunities for the vaccine cold chain logistics market in the next few years.
  • Vaccine Cold Chain Logistics MarketRegional Analysis: North America majorly contributed to the vaccine cold chain logistics market in 2021 owing to the surging government initiatives for logistics infrastructure and the growing demand for cold chain storages systems.
  • The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 byServices
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Packaging Methods
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Mode of Transportation
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Holding Temperature Range
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Container
    The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2028 by Region

INmune Bio, Inc. Announces Research Collaboration with Chinese University of Hong Kong to Evaluate INKmune in Nasopharyngeal Cancer

Retrieved on: 
Tuesday, January 25, 2022
U.S. Securities and Exchange Commission, Multiple myeloma, TME, Cytokine, Head, Security (finance), Squamous cell carcinoma, Process control block, Patient, UCL, Chinese University of Hong Kong, Dry ice, IL4, GLOBE, EBV, Neoplasm, TGF, Lymphoma, Inflammation, Ovarian cancer, Clinical trial, Private Securities Litigation Reform Act, TNF, IL15, Time, IL10, Toxic epidermal necrolysis, Leukemia, CUHK, Breast cancer, Cell, University College London, Cancer, Immune system, NK, Safety, Cytokine release syndrome, Research, Memory, IL12, Disease, Company, CIML, History, Protein, IL2, Marketing, Survival, NPC, Incidence, Epstein–Barr virus infection, IL18, NASDAQ, Mortality, Natural killer cell, Vaccine, Pharmaceutical industry

We are confident that these INKmune primed cells will kill NPC tumor cells very effectively and we look forward to a mutually beneficial collaboration.

Key Points: 
  • We are confident that these INKmune primed cells will kill NPC tumor cells very effectively and we look forward to a mutually beneficial collaboration.
  • History of EBV infection (commonly known as mono) and genetic polymorphisms drive the incidence of the disease, said RJ Tesi, INmune Bios Chief Executive Officer.
  • This peer-reviewed grant and international collaboration targeting what has historically been a difficult to treat solid tumor validates the versatility of INKmune.
  • Tumor-primed NK (TpNK) cells can lyse a wide variety of NK-resistant tumors including leukemias, lymphomas, myeloma, ovarian cancer, breast cancer.

UPS Surpasses One Billion COVID-19 Vaccine Delivery Milestone, Continues to Deliver Hope Around the World

Retrieved on: 
Tuesday, December 14, 2021
People, Weather, Organization, Solution, Dry ice, COVID, Marken, Unique, NYSE, UPS, Movement, Environment, Puppy Up Foundation, COVID-19, Vaccine, COVAX, Ultra, DNA, Health care, Zip line, GLOBE, Partnership, Pharmaceutical industry

Just one year after the first vaccine was delivered by UPS, this milestone was made possible through UPSs innovative approaches, one-of-a-kind UPS Premier tracking technologies, industry-leading cold chain solutions , and an expansive, sophisticated, global network supporting UPS Healthcare customers and communities around the world.

Key Points: 
  • Just one year after the first vaccine was delivered by UPS, this milestone was made possible through UPSs innovative approaches, one-of-a-kind UPS Premier tracking technologies, industry-leading cold chain solutions , and an expansive, sophisticated, global network supporting UPS Healthcare customers and communities around the world.
  • UPS Healthcare has set the global pace for COVID-19 vaccine delivery, supported by the unmatched dedication of UPSers and the companys global logistics capabilities and expertise, said UPS Healthcare President Wes Wheeler.
  • Medicines derived from biologics and delivered via cutting edge cold chain networks represent the future of healthcare, and UPS Healthcare is leading the way.
  • UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world.

UPS Surpasses One Billion Covid-19 Vaccine Delivery Milestone, Continues To Deliver Hope Around The World

Retrieved on: 
Tuesday, December 14, 2021
People, Weather, Organization, Solution, Dry ice, COVID, Marken, Global health, Unique, NYSE, UPS, Movement, Environment, Puppy Up Foundation, COVID-19, Vaccine, UPS Airlines, Ultra, DNA, Health care, GLOBE, Technology, Pharmaceutical industry, Aquaculture, COVAX

ATLANTA, Dec. 14, 2021 (GLOBE NEWSWIRE) -- UPS (NYSE: UPS) today announced that it surpassed the one billion COVID-19 vaccine doses delivered mark with near-perfect on-time delivery.

Key Points: 
  • ATLANTA, Dec. 14, 2021 (GLOBE NEWSWIRE) -- UPS (NYSE: UPS) today announced that it surpassed the one billion COVID-19 vaccine doses delivered mark with near-perfect on-time delivery.
  • UPS Healthcare has set the global pace for COVID-19 vaccine delivery, supported by the unmatched dedication of UPSers and the companys global logistics capabilities and expertise, said UPS Healthcare President Wes Wheeler.
  • Medicines derived from biologics and delivered via cutting edge cold chain networks represent the future of healthcare, and UPS Healthcare is leading the way.
  • UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world.

Thermal Custom Packaging is Revolutionizing the Frozen Food Delivery Business with Environmentally Friendly, Green Alternative to Dry Ice

Retrieved on: 
Tuesday, December 7, 2021
HDPE, Environment, Carbon, Temperature, CO2, Burn, Skin, RNA transfection, Efficiency, Glade, Climate, Dry ice, COVID-19, PCM, Solution, TCP, Refrigeration, Salt, Food preservation

Currently, food delivery is possible using insulated packaging and dry ice to keep perishable food frozen in transit.

Key Points: 
  • Currently, food delivery is possible using insulated packaging and dry ice to keep perishable food frozen in transit.
  • Dry ice is compressed frozen CO2, which is the main greenhouse gas that leads to global warming.
  • However, no amount of refrigeration will keep dry ice frozen; it begins sublimating right after it is formed.
  • Our alternative to dry ice provides an environmentally friendly, green option for the world, shared Director of TCP, Dr. Clifford Glade.